Ann Lab Med.  2015 Jan;35(1):123-127. 10.3343/alm.2015.35.1.123.

Performance of LIFECODES HLA-DQB1 Typing Kit Using Luminex Platform in Koreans

Affiliations
  • 1Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. eysong1@snu.ac.kr
  • 2Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
  • 3Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Medical Research Center, Seoul National University, Seoul, Korea.

Abstract

Intermediate-resolution HLA-DQ typing has gained importance in organ transplantation recently. We evaluated the performance of the LIFECODES HLA-DQB1 typing kit (Immucor, USA) using sequence-specific oligonucleotide (SSO) probe and Luminex platform (Luminex Corp., USA) on 100 samples tested by sequence-based typing (SBT) using the AlleleSEQR HLA-DQB1 kit (Abbott Molecular, USA) in Korean individuals. No sample showed ambiguity in the assignment of 4-digit HLA-DQB1 allele with the LIFECODES HLA-DQB1 SSO typing kit, and the results were fully concordant with those of high-resolution typing of AlleleSEQR HLA-DQB1 SBT up to 4-digit level. Three samples required adjustment of false reactions (3/100, 3.0%): two samples with DQB1*03:03/*06:01 showed false-positive result in probe 253, and 1 sample with DQB1*04:02/*05:02 showed false-negative result in probe 217. We tested an additional sample with DQB1*03:03/*06:01, which showed same false-positivity in probe 253 and 2 samples with DQB1*04:02/*05:02, which showed no false reaction. The false reactions did not result in ambiguity or change in the HLA allele assignment. We could assign HLA-DQB1 alleles to 4 digit-level without ambiguity, with 100% concordance with the SBT results. Thus, LIFECODES HLA-DQB1 SSO typing kit showed good performance for intermediate-resolution HLA-DQB1 typing in clinical laboratory for organ transplantation in Koreans.

Keyword

HLA-DQB1; PCR-SSO; Luminex; Korean; Organ transplantation

MeSH Terms

Alleles
DNA Primers/metabolism
Gene Frequency
Genotype
HLA-DQ beta-Chains/*genetics/metabolism
Histocompatibility Testing/*standards
Humans
Polymerase Chain Reaction
Reagent Kits, Diagnostic/*standards
Republic of Korea
DNA Primers
HLA-DQ beta-Chains
HLA-DQB1 antigen
Reagent Kits, Diagnostic

Cited by  2 articles

Association of HLA-DRB1 and -DQB1 Alleles with Susceptibility to IgA Nephropathy in Korean Patients
Ji Won In, Kiwook Jung, Sue Shin, Kyoung Un Park, Hajeong Lee, Eun Young Song
Ann Lab Med. 2022;42(1):54-62.    doi: 10.3343/alm.2022.42.1.54.

Allele and Haplotype Frequencies of Human Leukocyte Antigen-A, -B, -C, -DRB1, and -DQB1 From Sequence-Based DNA Typing Data in Koreans
Ji Won In, Eun Youn Roh, Sohee Oh, Sue Shin, Kyoung Un Park, Eun Young Song
Ann Lab Med. 2015;35(4):429-435.    doi: 10.3343/alm.2015.35.4.429.


Reference

1. Tambur AR, Rosati J, Roitberg S, Glotz D, Friedewald JJ, Leventhal JR. Epitope analysis of HLA-DQ antigens: what does the antibody see? Transplantation. 2014; 98:157–166. PMID: 25003284.
2. Lachmann N, Todorova K, Schulze H, Schönemann C. Luminex® and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion. Transfus Med Hemother. 2013; 40:182–189. PMID: 23922543.
Article
3. Trajanoski D, Fidler SJ. HLA typing using bead-based methods. Methods Mol Biol. 2012; 882:47–65. PMID: 22665228.
Article
4. Testi M, Iannelli S, Testa G, Troiano M, Capelli S, Fruet F, et al. Evaluation of DRB1 high resolution typing by a new SSO-based Luminex method. Mol Biol Rep. 2012; 39:13–16. PMID: 21424786.
Article
5. Song EY, Park MH, Kang SJ, Park HJ, Kim BC, Tokunaga K, et al. HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens. 2002; 59:475–486. PMID: 12445317.
Article
6. Roh EY, Park MH, Park H, Park DH, Choi JB, Kim SJ, et al. Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB1*1501-DQB1*0602--positive subjects. Hum Immunol. 2006; 67:749–755. PMID: 17002906.
7. DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, et al. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. Kidney Int. 2012; 82:598–604. PMID: 22622504.
Article
8. Willicombe M, Brookes P, Sergeant R, Santos-Nunez E, Steggar C, Galliford J, et al. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy. Transplantation. 2012; 94:172–177. PMID: 22735711.
Article
9. Tambur AR, Leventhal JR, Friedewald JJ, Ramon DS. The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. Transplantation. 2010; 90:1117–1124. PMID: 20847715.
Article
10. Claas FH, Rahmel A, Doxiadis II. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation. 2009; 88:447–452. PMID: 19696624.
Article
11. Saito S, Ota S, Yamada E, Inoki H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens. 2000; 56:522–529. PMID: 11169242.
Article
12. Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003; 73:720–735. PMID: 14508706.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr